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Abstracts / Osteoarthritis and Cartilage 23 (2015) A26eA81A48enhancement of synovium during dynamic contrast enhanced mag-
netic resonance imaging (DCE-MRI) correlate more strongly with
reduction in pain severity than changes in static synovial volume. The
aim of this analysis was to determine the impact of a PFJ brace on
synovitis as assessed by change in synovial enhancement using DCE-
MRI.
Methods: One hundred and twenty six people aged between 40 and 70
years with PFJ OA were recruited into a randomised clinical trial of a
patellar brace. Participants were randomised to an intervention
(wearing brace) and a control group (no brace) for six weeks. Subjects
were assessed at baseline and at 6 weeks for pain using the KOOS
questionnaire and also a visual analogue score (VAS) scored from 0-
100mm for a nominated physical activity (VASNA). They also had DCE-
MRI of the symptomatic knee performed at baseline and at 6 weeks.
Dynamic synovial parameters were calculated based on the enhance-
ment of synovium with contrast including; maximum rate of
enhancement (max-grad), late relative enhancement (late-rel), max-
imum enhancement (max) and volume transfer coefﬁcient (ktrans). We
used a paired t-test to look at within group change in both pain and
DCE-MRI parameters before and after intervention and an unpaired t-
test to look at the between group difference in the change in these
parameters.
Results: Subjects’ mean age was 55.5 years (SD ¼ 7.5) and 72 (57.1%)
were female. Pain improved signiﬁcantly within the intervention group
though not the control group. There was a signiﬁcant between group
difference in the change in both KOOS and VASNA, see Table. Within
controls there was a reduction in all of the dynamic parameters
between baseline and follow up. This was signiﬁcant for volume
transfer coefﬁcient (within group difference in ktrans ¼ -0.003) and
also maximum rate of enhancement (within group difference in max-
grad ¼ -0.198). Within the intervention group there was a small
increase (worsening) in all of the dynamic MRI parameters between
baseline and 6 weeks follow up though none of these differences was
statistically signiﬁcant. There was a signiﬁcant difference in the change
in maximum rate of enhancement (max) between the intervention and
control groups.
Conclusions: Patellofemoral joint brace therapy for patients with
symptomatic patellofemoral knee OA does not reduce synovitis as
suggested by change in synovial enhancement using DCE-MRI. Pain
reduction following brace therapy can not therefore be explained by
change in synovitis.Table 1
Changes in Dynamic MRI Factors Following Brace Intervention
Variables No brace group (N¼63) Brace group (N¼63)
Within group mean diff (95% CI) p Within group mean diff (95% CI) p Between-group mean diff (95% CI) p
ktrans 0.003 (0.006 to 0.000) 0.05 0.001 (0.003 to 0.005) 0.63 0.002 (0.009 to 0.001) 0.11
max_grad 0.198 (0.345 to 0.050) 0.01 0.171 (0.013 to 0.356) 0.07 0.116 (0.599 to 0.139) <0.01
late_rel 0.102 (0.280 to 0.076) 0.25 0.010 (0.175 to 0.195) 0.91 0.128 (0.367 to 0.142) 0.38
max 0.161 (0.357 to 0.036) 0.11 0.045 (0.166 to 0.256) 0.67 0.143 (0.491 to 0.079) 0.15
Pain on nominated activity VAS 0.13 (0.64 to 0.38) 0.61 1.82 (2.39 to 1.24) <0.01 0.38 (0.93 to 2.44) <0.01
KOOS Pain Subscale Score 1.71 (1.66 to 5.08) 0.31 8.78 (4.36 to 13.20) <0.01 2.75 (12.51 to 1.61) 0.0141
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Purpose:While osteoarthritis (OA) is the most frequent type of arthritis
in the population, relatively little attention has been paid to patients’
perceptions of the impact of their disease and the barriers they face in
receiving care. This study examined current treatments and barriers to
treatment, as well as perceptions around decision making and the
preferences of patients for physician input into their OA treatment.
Methods: A poll of people with arthritis was commissioned to gather
data on patient perceptions with the purpose of improving the infor-
mation presented on The Arthritis Society of Canada website.
Respondents were asked for their disease diagnosis; impact of arthritis
(e.g., pain, fatigue, disability with activities and social roles); barriers
and challenges in getting care; and preferences for physicianinvolvement in care decisions. Most questions were on a 1 to 5 scale
ranging from 1 ¼ no impact/importance to 5 ¼ extreme impact/
importance. Scores are reported as means or percentages unless oth-
erwise stated.
Results: Of the 1715 respondents, 922 (53.8%) reported osteoarthritis
(OA) and 588 (34.3%) reported OA as their sole type of arthritis.We focus
on those with OA as a sole diagnosis. Eighty two percent were female;
57% were aged 5 years. The mean pain intensity was 5.9 on a 1-10 scale
with 70% reporting pain at least once aweek. Themean number of joints
affectedwas 3.8 (out of 13). However, 44% of participants reported taking
no medications for their OA. The impact of OA on daily activities was
moderatewithmean scores in the range of 2.2-3.0 out of 5 for family and
social-related activities. The greatest impact of OAwas for exercise (3.3)
and intimate relations (4.4). Respondents reported controlling pain,
mobility and stiffness, loss of strength, fatigue, low energy and difﬁculty
sleeping as being of high importance (range ofmean scores 4.1-4.4) with
no differences by age. Overall 75% of respondents reported at least one
challenge in getting treatment with the top 3 challenges being a lack of
affordable treatment (30.1%), long wait times for appointments (28.3%),
and a perceived absence of beneﬁcial treatment (e.g., ”don’t think any-
thing can be done”) (26.3%). Costs for treatments like physiotherapy and
over-the-counter medication were noted in particular. Respondents
rated highly the importance of physicians considering their input when
making decisions related to prescription medication (mean ¼ 4.4) and
treatments such as surgery or physiotherapy (mean ¼ 4.4). However
they expressed lower perceived importance for seeking physician input
before deciding on treatments such as diet and exercise (mean¼3.7) and
over-the counter-medications (mean ¼ 3.8).
Conclusions: Despite pain, a moderate impact on valued roles and
activities, and a high importance of controlling a range of symptoms,
two-ﬁfths of people with OAwere not taking any medications, which is
in line with ﬁndings from other studies. Of concern was that most
respondents reported challenges and hardships with getting treatment,
including costs not covered by the health care system and a perception
that little was available to them in the way of efﬁcacious care for OA.
Moreover, clinician input was not always seen as important in man-
agement of all aspects of OA. There is a clear need for better information
for patients on what can be done to control their illness and for inter-
ventions to minimize barriers in accessing appropriate treatments.
Additional research on decision-making preferences related to OA
treatment would be beneﬁcial in addressing a patient-centred approach
to OA management.42
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Purpose: Folate-based radiotracers have been used in patients with
cancer and inﬂammatory diseases to visualize folate receptor express-
ing cells using PET or SPECT techniques. Activated macrophages express
folate receptor beta (FR-b) and this allows speciﬁc imaging of these cells
in-vivo. From previous work using SPECT imaging to visualize folate
receptor expressingmacrophages in both animal models and in patients
with OA we know that macrophages are present in OA affected joints.
However, it remains unclear what role these macrophages play in the
